Recognizing Refractory HSV and Leveraging New Treatment Pathways CME/CPE Thursday, September 10, 2026 | 1:30 pm - 2:00 pm ET Virtual

Recognizing Refractory HSV and Leveraging New Treatment Pathways CME/CPE Thursday, September 10, 2026 | 1:30 pm - 2:00 pm ET Virtual https://events.medscapelive.org/website/97712/?utm_source=mrk&utm_campaign=450555.11a_virtual_9-10_ssovirtual&utm_medium=em&utm_content=int Herpes simplex virus (HSV), one of the most common viral infections worldwide, has lifelong effects on neuronal ganglia. Patients with immunocompromising conditions are at increased risk for experiencing refractory HSV infections that are difficult to treat and prolonged in their symptoms. This 3-part series of live webinars takes clinicians on a progressive learning journey from understanding to application in refractory HSV care.